CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors.
Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)T细胞疗法可通过多种机制产生耐药,最常见的是抗原丢失和肿瘤诱导的免疫抑制。有观点认为,表达多个CAR的T细胞可能克服肿瘤耐药;而表达可将抑制性免疫检查点信号转化为共刺激信号的受体,可能增强T细胞在肿瘤微环境中的活性。然而,受当前基因递送载体转基因装载能力限制,很难在单一T细胞产品中整合多种工程化特征。本文介绍一种利用亮氨酸拉链,通过单步免疫磁纯化选择同时接受两种载体转导细胞的方法。该“Zip分选”技术可制备同时表达多达4种CAR并共表达多达3种“转换”受体的T细胞。在同基因小鼠模型中,表达多种CAR和多种转换受体的T细胞能够清除共表达多种抑制性配体、具有抗原异质性的白血病细胞群。通过结合多种治疗策略,Zip分选的多CAR、多转换受体T细胞能够克服多种CAR-T 细胞耐药机制。
Resistance to chimaeric antigen receptor (CAR) T cell therapy develops through multiple mechanisms, most notably antigen loss and tumour-induced immune suppression. It has been suggested that T cells expressing multiple CARs may overcome the resistance of tumours and that T cells expressing receptors that switch inhibitory immune-checkpoint signals into costimulatory signals may enhance the activity of the T cells in the tumour microenvironment.
However, engineering multiple features into a single T cell product is difficult because of the transgene-packaging constraints of current gene-delivery vectors.
Here we describe a cell-sorting method that leverages leucine zippers for the selective single-step immunomagnetic purification of cells co-transduced with two vectors. Such 'Zip sorting' facilitated the generation of T cells simultaneously expressing up to four CARs and coexpressing up to three 'switch' receptors.
In syngeneic mouse models, T cells with multiple CARs and multiple switch receptors eliminated antigenically heterogeneous populations of leukaemia cells coexpressing multiple inhibitory ligands. By combining diverse therapeutic strategies, Zip-sorted multi-CAR multi-switch-receptor T cells can overcome multiple mechanisms of CAR T cell resistance.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。